Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hormone Therapy”

2,441 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 2,441 results

Large-scale testing (Phase 3)UnknownNCT01352091
What this trial is testing

Adjuvant AI Combined With Zoladex

Who this might be right for
Breast Cancer
Fudan University 670
Post-approval studies (Phase 4)Study completedNCT03338855
What this trial is testing

Effects of 5 Weeks Treatment With Dapagliflozin in Type 2 Diabetes Patients on How the Hormone Insulin Acts on Sugar Uptake in Muscles.

Who this might be right for
Diabetes Mellitus, Type 2Skeletal Muscle Insulin Sensitivity
AstraZeneca 26
Large-scale testing (Phase 3)Study completedNCT00390455
What this trial is testing

Fulvestrant With or Without Lapatinib in Treating Postmenopausal Women With Stage III or Stage IV Breast Cancer That is Hormone Receptor-Positive

Who this might be right for
Estrogen Receptor PositiveHER2 Positive Breast CarcinomaHER2/Neu Negative+5 more
National Cancer Institute (NCI) 295
Testing effectiveness (Phase 2)WithdrawnNCT05130086
What this trial is testing

Islatravir (MK-8591) in Trans and Gender Diverse Participants (MK-8591-035)

Who this might be right for
Human Immunodeficiency Virus (HIV) Infections
Merck Sharp & Dohme LLC
Testing effectiveness (Phase 2)UnknownNCT04318223
What this trial is testing

Palbociclib Plus Fulvestrant in Women With Hormone Receptor Positive and Human Epidermal Growth Factor Receptor Type 2 Negative Locally Advanced or Metastatic Breast Cancer Previously Treated With a CDK4/6 Inhibitor in Combination With Hormonal Therapy

Who this might be right for
Metastatic Breast CancerLocally Advanced Breast Cancer
Consorzio Oncotech 168
Early research (Phase 1)Study completedNCT01969643
What this trial is testing

A Safety Study of SGN-LIV1A in Breast Cancer Patients

Who this might be right for
HER2 Positive Breast NeoplasmsHormone Receptor Positive Breast NeoplasmsTriple Negative Breast Neoplasms+1 more
Seagen Inc. 290
Testing effectiveness (Phase 2)Study completedNCT00034047
What this trial is testing

Endometriosis : Traditional Medicine vs Hormone Therapy

Who this might be right for
EndometriosisPelvic Pain
National Center for Complementary and Integrative Health (NCCIH) 50
Large-scale testing (Phase 3)WithdrawnNCT00256555
What this trial is testing

Growth Hormone Treatment Study in Children With Cystic Fibrosis

Who this might be right for
Cystic Fibrosis
University of Texas Southwestern Medical Center
Testing effectiveness (Phase 2)Ended earlyNCT00103376
What this trial is testing

Bortezomib With or Without Hormone Therapy in Treating Patients With Relapsed Prostate Cancer

Who this might be right for
Prostate Cancer
Medical University of South Carolina 23
Testing effectiveness (Phase 2)Study completedNCT00589420
What this trial is testing

Sorafenib and Docetaxel in Patients With Prostate Cancer That Did Not Respond to Previous Hormone Therapy

Who this might be right for
Prostate Cancer
Abramson Cancer Center at Penn Medicine 18
Post-approval studies (Phase 4)Study completedNCT04354896
What this trial is testing

The Effect of Thyroid Hormone Therapy on Muscle Mass and Function in Older Adults With Subclinical Hypothyroidism

Who this might be right for
Subclinical HypothyroidismSarcopenia
Insel Gruppe AG, University Hospital Bern 322
Testing effectiveness (Phase 2)Study completedNCT01227980
What this trial is testing

Corticotropin-Releasing Hormone Receptor 1 (CRH1) Antagonism in Anxious Alcoholics^

Who this might be right for
Alcohol-Related DisordersAlcohol DependenceAlcoholism+1 more
National Institute on Alcohol Abuse and Alcoholism (NIAAA) 70
Not applicableUnknownNCT03651427
What this trial is testing

Cross-sex Hormone Therapy and Neuronal Plasticity

Who this might be right for
Gender Dysphoria
Hospital de Clinicas de Porto Alegre 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT06463457
What this trial is testing

Comeback From Long coursE Androgen Deprivation Therapy (ADT) With RElugolix and Darolutamide (CLEARED)

Who this might be right for
Prostate CancerAdvanced Prostate CancerHormone Sensitive Prostate Cancer
Atish Choudhury, MD 33
Not applicableStudy completedNCT03834701
What this trial is testing

Endoscopic Ultrasound-guided RadioFrequency Ablation for the Treatment Pancreatic NeuroEndocrine Neoplasms

Who this might be right for
Neuroendocrine TumorsNeuroendocrine CarcinomaPancreas Neoplasm+1 more
Catholic University of the Sacred Heart 60
Large-scale testing (Phase 3)Study completedNCT01746862
What this trial is testing

Evaluate the Safety and Efficacy of Saizen® in Children With Idiopathic Short Stature (ISS)

Who this might be right for
Idiopathic Short Stature
Merck KGaA, Darmstadt, Germany 90
Not applicableUnknownNCT02208583
What this trial is testing

Molecular Phenotype Changes and Personalized Treatment for CRPC

Who this might be right for
Hormone Refractory Prostate Cancer
Tianjin Medical University Cancer Institute and Hospital 150
Testing effectiveness (Phase 2)Ended earlyNCT00176631
What this trial is testing

Licorice Root Extract and Docetaxel in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy

Who this might be right for
Prostate Cancer
Rutgers, The State University of New Jersey 10
Large-scale testing (Phase 3)Looking for participantsNCT05974774
What this trial is testing

Intermittent Androgen Deprivation Therapy in the Era of AR Pathway Inhibitors

Who this might be right for
Prostate Cancer
European Organisation for Research and Treatment of Cancer - EORTC 1,600
Testing effectiveness (Phase 2)WithdrawnNCT04374279
What this trial is testing

Trial to Promote Recovery From COVID-19 With Endocrine Therapy

Who this might be right for
COVID-19SARS-CoV 2
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Load More Results